ORPHA:93293
Okihiro syndrome
Also known as: Duane-radial ray syndrome
Publications
5,800
Trials
0
Interventional, condition-specific
Researchers
1,103
Distinct authors in sample
Gene link
SALL4
Definitive
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare multiple anomalies syndrome characterized by the association of uni- or bilateral radial defects, uni- or bilateral Duane anomaly ( limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure), renal abnormalities, sensorineural and/or conductive hearing loss, and, less frequently, imperforate anus and scoliosis.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0011812
- OMIM:607323
- UMLS:C1623209
Additional Mondo synonyms (4)
DR syndrome · DRRS · Duane anomaly with radial ray abnormalities and deafness · acro-renal-ocular syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
No matched interventional trial, but a gene association and an animal model are on record — often described as translation-ready / stalled at the clinical step.
- Gene identifiedPresent
Definitive — SALL4
- LiteraturePresent
5,800 matched papers (4,370 in last 10 years) Source
- Phenotype characterisedPresent
98 HPO annotations (e.g. Horseshoe kidney; Abnormal morphology of the radius; Crossed fused renal ectopia) Source
- Animal modelPresent
4 genotype models (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (SALL4).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
98
Associated phenotypes · MONDO:0011812
- Horseshoe kidney
- Abnormal morphology of the radius
- Crossed fused renal ectopia
- Sandal gap
- Hypoplasia of the ulna
Showing 5 of 98 — open Monarch for the full list.
Animal models (Monarch / Alliance)
4
Model associations linked to this Mondo ID
- Sall4Gt(XE027)Byg/Sall4+ [background:] B6;129P2-Sall4Gt(XE027)Byg·MGI:3617909·Mus musculus
- Sall4tm1Ryn/Sall4+ [background:] involves: 129P2/OlaHsd * C57BL/6J·MGI:3699203·Mus musculus
- Sall4tm1Brd/Sall4+ [background:] involves: 129S7/SvEvBrd * C57BL/6J·MGI:3698627·Mus musculus
- Sall4Gt(XE027)Byg/Sall4+ [background:] involves: 129P2/OlaHsd * Black Swiss * C57BL/6·MGI:3617910·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
5,800
5,800 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
5,800 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
4,370 in the last 10 years · low confidence
Phrase hits: 311 · MeSH hits: 0
Who's working on it?
1,103
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Kohlhase J14 papers · 2008
Institut für Humangenetik, Georg-August-Universität Göttingen, Heinrich-Düker-Weg 12, 37073 Göttingen, Germany. jkohlha@gwdg.de
Papers in Europe PMC - 02Chai L8 papers · 2016
Department of Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. lchai@partners.org
Papers in Europe PMC - 03Engle EC8 papers · 2025
Department of Medicine, Program in Genomics, Boston, Massachusetts, USA
Papers in Europe PMC - 04Yang J7 papers · 2025
State Key Laboratory of Cardiovascular Diseases, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. jy279@tongji.edu.cn.
Papers in Europe PMC - 05
- 06Ma Y6 papers · 2014
Department of Pathology; The State University of New York at Stony Brook; Stony Brook, NY USA.
Papers in Europe PMC - 07Zhang X6 papers · 2025
Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.
Papers in Europe PMC - 08
- 09Böhm J4 papers · 2008
Institut für Humangenetik und Anthropologie, Universität Freiburg, Freiburg, Germany.
Papers in Europe PMC - 10
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT03059420·RECRUITING·Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Conditions: Congenital Fibrosis of Extraocular Muscles · Duane Retraction Syndrome · Duane Radial Ray Syndrome · Mobius Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN17340368·Not yet recruiting·A study testing new HIV treatment options for children and adolescents in Africa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17701271·Not yet recruiting·129Xenon MRI study of the effects of Mepolizumab on inflammation in the lungs of patients with chronic obstructive pulmonary disease (COPD)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13024576·Not yet recruiting·Assessing the safety and value of shortened heart ultrasound scan protocols
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN69014227·Not yet recruiting·Mental practice for arm recovery early after stroke
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN37673511·Recruiting·Evaluation of a cosmetic product in helping to reduce and prevent stretch marks in pregnant women and people experiencing rapid weight changes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66692567·Not yet recruiting·A study of brain activity in visual snow syndrome and migraine
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN72157798·Recruiting·Developing a vaccine against Bundibugyo ebolavirus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17148628·Not yet recruiting·A study to evaluate the tolerability and the effects on the immune system of a tetanus and diphtheria vaccine which does not need any cold chain distribution or storage
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14269651·No longer recruiting·Does an absorbable poloxamer and sodium alginate gel applied during lower-back (lumbar) spine surgery reduce scar tissue and improve recovery?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34498249·Recruiting·A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3-stage metabolic dysfunction-associated steatohepatitis (BOS-580-302)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21343134·Recruiting·Exploring Symprove product for the management of gastroesophageal reflux disease (GORD) symptoms
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15642871·Recruiting·Investigating the role of dietary probiotics on athletic performance and health
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13207472·No longer recruiting·A two-part study in healthy volunteers to investigate the feasibility of a combined test medicine formulation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11435073·Recruiting·Can children in hospital safely switch from antibiotics given through a vein to antibiotics taken by mouth? A study to assess whether this approach is practical, effective, and can reduce hospital stay and treatment costs in Egypt
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10621395·Recruiting·CAR-T cells for children with CNS tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11929806·Recruiting·A study to evaluate Adex Gel in the treatment of actinic keratosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN28813846·Recruiting·Would genetic testing improve the diagnosis and treatment of patients with a neurodevelopmental psychiatric disorder?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17213765·No longer recruiting·A study comparing two minimally invasive injection-based treatments for lumbar disc herniation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12510191·Not yet recruiting·A feasibility study of a smartphone app to support mental well-being in people with Long COVID
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16150360·Not yet recruiting·Investigating the impact of kefir on metabolic syndrome subjects in an inpatient setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17037497·Recruiting·A study of JNJ-95804306 for relapsed or refractory hematological malignancies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15307328·Recruiting·Leigh syndrome roadmap project: a natural history study (UK)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26393895·Recruiting·Effects of electronic cigarettes and traditional cigarettes on brain structures
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15819396·Recruiting·A Phase I/IIa trial of KJ-103 in solid cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98606172·Recruiting·Personalising treatment for myeloma patients based on initial response to NHS treatment and their overall fitness level
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Okihiro syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Okihiro syndrome" OR "Duane-radial ray syndrome" OR "DR syndrome" OR "Duane anomaly with radial ray abnormalities and deafness" OR "acro-renal-ocular syndrome") OR ("SALL4" OR "SALL4 syndrome" OR "SALL4-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Okihiro syndrome" OR "Duane-radial ray syndrome" OR "DR syndrome" OR "Duane anomaly with radial ray abnormalities and deafness" OR "acro-renal-ocular syndrome"
Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: DRRS
Confidence reasoning
- Preferred label is short or not clearly distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- "acro-renal-ocular syndrome" also appears on ORPHA:959
- Publication count (5800) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T04:12:34.290Z
